[1]王远航,沈艳新,刘琬莹.护理风险管理在老年冠心病患者介入治疗中的应用[J].医学信息,2024,37(07):152-155.[doi:10.3969/j.issn.1006-1959.2024.07.031]
　WANG Yuan-hang,SHEN Yan-xin,LIU Wan-ying.Application of Nursing Risk Management in Interventional Therapy of Elderly Patients with Coronary Heart Disease[J].Journal of Medical Information,2024,37(07):152-155.[doi:10.3969/j.issn.1006-1959.2024.07.031]
点击复制

护理风险管理在老年冠心病患者介入治疗中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年07期
页码:
152-155
栏目:
护理研究
出版日期:
2024-04-01

文章信息/Info

Title:
Application of Nursing Risk Management in Interventional Therapy of Elderly Patients with Coronary Heart Disease
文章编号:
1006-1959（2024）07-0152-04
作者:
王远航; 沈艳新; 刘琬莹
（佳木斯市中心医院心内科，黑龙江 佳木斯 154002）
Author(s):
WANG Yuan-hang; SHEN Yan-xin; LIU Wan-ying
(Department of Cardiology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
冠心病; 介入治疗; 老年患者; 护理风险管理; 凝血功能; 血栓形成
Keywords:
Coronary heart disease; Interventional therapy; Elderly patients; Nursing risk management; Coagulation function; Thrombosis
分类号:
R473.5
DOI:
10.3969/j.issn.1006-1959.2024.07.031
文献标志码:
A
摘要:
目的 探究护理风险管理在老年冠心病患者介入治疗中的应用价值。方法 以2019年8月-2021年8月于佳木斯市中心医院行介入治疗的50例老年冠心病患者为研究对象，依据随机数字表法分为对照组（25例）与观察组（25例）。对照组行常规护理管理，观察组在其基础上开展护理风险管理，比较两组术后康复指标（出血时间、完全松懈压迫时间、术后住院时间）、凝血功能[凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）]、手术并发症、主要不良心脑血管事件（MACCE）、护理风险事件、纠纷投诉事件及护理满意度。结果 观察组术后出血时间、完全松懈压迫时间以及术后住院时间短于对照组（P＜0.05）；观察组术后PT、APTT指标低于对照组（P＜0.05）；观察组手术并发症发生率低于对照组（P＜0.05）；观察组护理风险事件、纠纷投诉事件发生率低于对照组（P＜0.05）；观察组护理满意率高于对照组（P＜0.05）。结论 护理风险管理在老年冠心病患者介入治疗中具有较高应用价值，可加快康复进展，改善患者术后凝血指标，降低其并发症风险，同时减少护理风险事件及纠纷投诉，满意度反馈良好。
Abstract:
Objective To explore the application value of nursing risk management in interventional therapy of elderly patients with coronary heart disease.Methods A total of 50 elderly patients with coronary heart disease who underwent interventional therapy in Jiamusi Central Hospital from August 2019 to August 2021 were divided into control group (25 patients) and observation group (25 patients) according to random number table method. The control group was given routine nursing management, and the observation group was given nursing risk management on the basis of the control group. The postoperative rehabilitation indexes (bleeding time, complete relaxation compression time, postoperative hospital stay), coagulation function [prothrombin time (PT), activated partial thromboplastin time (APTT)], surgical complications, major adverse cardiovascular and cerebrovascular events (MACCE), nursing risk events, dispute complaints and nursing satisfaction were compared between the two groups.Results The postoperative bleeding time, complete relaxation compression time and postoperative hospital stay in the observation group were shorter than those in the control group (P<0.05). The indexes of PT and APTT in the observation group were lower than those in the control group (P<0.05). The incidence of surgical complications in the observation group was lower than that in the control group(P<0.05). The incidence of nursing risk events and dispute complaints in the observation group was lower than that in the control group (P<0.05). The nursing satisfaction rate of the observation group was higher than that of the control group(P<0.05).Conclusion Nursing risk management has high application value in interventional therapy of elderly patients with coronary heart disease, which can accelerate the progress of rehabilitation, improve the postoperative coagulation index of patients, reduce the risk of complications. Meanwhile, it can reduce nursing risk events and dispute complaints, as well as the satisfaction feedback is good.

参考文献/References:

[1]白静,于一,王严,等.血运重建程度对老年冠心病合并糖尿病患者经皮介入治疗术后临床预后的影响[J].中华老年心脑血管病杂志,2018,20(3):229-233.[2]宋兵战,孙庆霞,蒋静.无缝隙护理在冠心病介入治疗中的应用效果[J].实用心脑肺血管病杂志,2021,29(1):196-197.[3]郭丽敏,刘柳,周欢.综合护理干预对经皮冠状动脉介入治疗的影响[J].河北医药,2021,43(9):1424-1426.[4]周学中,王惠,罗太阳.经皮冠脉介入治疗老年冠心病患者的预后及其影响因素[J].江苏大学学报(医学版),2018,28(6):512-515.[5]顾品花.护理风险管理应用在冠心病介入治疗患者中的临床效果研究[J].世界中医药,2017,12(1):194-195．[6]中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,等.稳定性冠心病诊断与治疗指南[J].中华心血管病杂志,2018,46(9):680-694.[7]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.[8]于亚梅,余云华,李然,等.老年冠心病患者介入治疗血运重建方式临床疗效分析[J].介入放射学杂志,2017,26(1):6-9.[9]张晓萍,马琳,周桂玲,等.经皮冠状动脉介入术治疗老年冠心病的预后及其影响因素[J].中国循证心血管医学杂志,2017,9(7):848-850,853.[10]李春镭,方文云,吴婷.老年冠心病患者经皮冠状动脉介入术后近期预后及其相关影响因素分析[J].中国慢性病预防与控制,2018,26(9):680-682.[11]李小娟,韩小宏.针对性护理干预措施对冠心病介入治疗患者术后并发症的预防效果[J].实用临床医药杂志,2017,21(20):47-49,56.[12]许丽华,王银花.冠心病患者行介入术后常见并发症与护理体会[J].国际心血管病杂志,2017,44(1):256-257．[13]Harada M,Miura T,Kobayashi T,et al.Clinical impact of complete revascularization in elderly patients with multi-vessel coronary artery disease undergoing percutaneous coronary intervention: A sub-analysis of the SHINANO registry[J].International Journal of Cardiology,2017,230(1):413-419.[14]程浩,王馨,闫美辰,等.经股动脉径路和经桡动脉径路冠心病介入诊疗术后外周血管并发症发生原因及相关护理[J].河北医药,2018,40(19):3035-3037.[15]钱蕾,葛兆霞.全局式护理在冠心病介入治疗患者中的应用及临床效果观察[J].护士进修杂志,2017,32(11):1032-1034.[16]吴秀华,李玲,朱夏玲,等.冠心病介入诊疗术后血管并发症的原因及护理对策分析[J].中国生化药物杂志,2017,37(11):317-318．[17]黄莹,孙力,范瑞.经皮冠状动脉介入治疗术后亚急性支架内血栓形成并发肝功能异常患者的药学服务[J].药学实践杂志,2019,37(2):183-187.[18]林静,曾德菲,黄滟,等.精准化护理干预在冠心病患者介入治疗中的应用[J].西部医学,2019,31(11):1785-1789.[19]刘芳,常芸,吴筱娴.冠心病介入治疗术后连续性护理的实施效果评价[J].中国实用护理杂志,2017,33(16):1223-1226.[20]Sokoloff A,Picard F,Degrell P,et al.Antiplatelet duration in the elderly patients after percutaneous coronary intervention[J].Ann Cardiol Angeiol (Paris),2018,67(6):411-416.[21]饶建云,张瑞,范婷.预见性护理在冠心病介入治疗患者中的应用效果评价[J].护理实践与研究,2018,15(13):40-42.[22]李红文,张玉莲.护理风险管理在老年冠心病患者介入手术护理中的应用探讨[J].山西医药杂志,2017,46(15):1889-1891.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(07):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[3]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(07):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[4]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[5]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(07):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[6]李 铎.β受体阻滞剂预处理对AMI介入治疗患者心室重构、 自主神经功能恢复的影响研究[J].医学信息,2018,31(09):91.[doi:10.3969/j.issn.1006-1959.2018.09.027]
　LI Duo.Effect of β-blocker Preconditioning on Ventricular Remodeling and Autonomic Nerve Function Recovery in Patients Undergoing AMI Intervention[J].Journal of Medical Information,2018,31(07):91.[doi:10.3969/j.issn.1006-1959.2018.09.027]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(07):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(07):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(07):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
　GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Journal of Medical Information,2018,31(07):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
[11]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(07):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[12]何进舟,陈德彬,郭厚玲.介入治疗对冠心病合并左心功能不全患者的心功能 及生活质量的影响[J].医学信息,2019,32(18):78.[doi:10.3969/j.issn.1006-1959.2019.18.024]
　HE Jin-zhou,CHEN De-bin,GUO Hou-ling.Effect of Interventional Therapy on Cardiac Function and Quality of Life in Patients with Coronary Heart Disease Complicated with Left Ventricular Dysfunction[J].Journal of Medical Information,2019,32(07):78.[doi:10.3969/j.issn.1006-1959.2019.18.024]
[13]王永智.经皮冠状动脉介入治疗冠心病研究进展[J].医学信息,2019,32(16):41.[doi:10.3969/j.issn.1006-1959.2019.16.013]
　WANG Yong-zhi.Progress in Percutaneous Coronary Intervention for Coronary Heart Disease[J].Journal of Medical Information,2019,32(07):41.[doi:10.3969/j.issn.1006-1959.2019.16.013]
[14]杨 骏.延续性自我管理教育对冠心病介入治疗患者生活质量的影响[J].医学信息,2021,34(14):181.[doi:10.3969/j.issn.1006-1959.2021.14.052]
　YANG Jun.The Effect of Continuous Self-management Education on the Quality of Life of Patients with Coronary Heart Disease Interventional Therapy[J].Journal of Medical Information,2021,34(07):181.[doi:10.3969/j.issn.1006-1959.2021.14.052]
[15]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(07):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]

更新日期/Last Update: 1900-01-01